Skip to main content
  • Periprocedural MI Should Not Be an Endpoint

    Great controversy erupted after the report of the EXCEL trial of percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with left main disease. I discussed it in this space in a piece I called, “What's Right about Left Main?” Much of that controversy was over the definition of periprocedural myocardial infarction (MI) used as a part of the composite endpoint of the trial.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details